Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer (mCRC) patients: a systematic literature review and meta-analysis

被引:0
|
作者
Bylsma, Lauren C. [1 ]
Levin-Sparenberg, Elizabeth D. [2 ]
Lowe, Kimberly [3 ]
Sangare, Laura [4 ]
Fryzek, Jon [5 ]
Alexander, Dominik D. [2 ]
机构
[1] EpidStrategies, Ann Arbor, MI USA
[2] EpidStat Inst, Ann Arbor, MI USA
[3] Amgen Inc, Seattle, WA USA
[4] SimulStat, Portland, OR USA
[5] EpidStrategies, Rockville, MD USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
906
引用
收藏
页码:440 / 440
页数:1
相关论文
共 50 条
  • [21] Prevalence of RAS and BRAF mutations in metastatic colorectal cancer (mCRC) patients by tumor location.
    Bylsma, Lauren C.
    Gillezeau, Christina
    Garawin, Tamer
    Kelsh, Michael Anthony
    Fryzek, Jon
    Sangare, Laura
    Lowe, Kimberly
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [22] Prevalence of BRAF gene mutation in samples of primary and metastatic colorectal cancer: A meta-analysis
    Moosazadeh, Mahmood
    Sadough, Azita
    Afshari, Mahdi
    Barzegari, Saeed
    Janbabaee, Ghasem
    Tabrizi, Reza
    Akbari, Maryam
    Alizadeh-Navaei, Reza
    Hedayatizadeh-Omran, Akbar
    Rostami-Maskopaee, Fereshteh
    EUROPEAN JOURNAL OF CANCER CARE, 2019, 28 (06)
  • [23] Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer
    Franczak, Claire
    Witz, Andrea
    Geoffroy, Karen
    Demange, Jessica
    Rouyer, Marie
    Husson, Marie
    Massard, Vincent
    Gavoille, Celine
    Lambert, Aurelien
    Gilson, Pauline
    Gambier, Nicolas
    Scala-Bertola, Julien
    Merlin, Jean-Louis
    Harle, Alexandre
    PLOS ONE, 2020, 15 (01):
  • [24] The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
    Therkildsen, Christina
    Bergmann, Troels K.
    Henrichsen-Schnack, Tine
    Ladelund, Steen
    Nilbert, Mef
    ACTA ONCOLOGICA, 2014, 53 (07) : 852 - 864
  • [25] KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis
    Formica, Vincenzo
    Sera, Francesco
    Cremolini, Chiara
    Riondino, Silvia
    Morelli, Cristina
    Arkenau, Hendrik-Tobias
    Roselli, Mario
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (04): : 517 - 527
  • [26] The frequency of NRAS and KRAS gene mutations in Turkish patients with metastatic colorectal carcinoma
    Ozcan, M.
    Elpek, O.
    Gelen, M. T.
    VIRCHOWS ARCHIV, 2016, 469 : S310 - S310
  • [27] KRAS/BRAF mutations in brain arteriovenous malformations: A systematic review and meta-analysis
    Bameri, Omid
    Salarzaei, Morteza
    Parooie, Fateme
    INTERVENTIONAL NEURORADIOLOGY, 2021, 27 (04) : 539 - 546
  • [28] KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study
    Negru, Serban
    Papadopoulou, Eirini
    Apessos, Angela
    Stanculeanu, Dana Lucia
    Ciuleanu, Eliade
    Volovat, Constantin
    Croitoru, Adina
    Kakolyris, Stylianos
    Aravantinos, Gerasimos
    Ziras, Nikolaos
    Athanasiadis, Elias
    Touroutoglou, Nikolaos
    Pavlidis, Nikolaos
    Kalofonos, Haralabos P.
    Nasioulas, George
    BMJ OPEN, 2014, 4 (05):
  • [29] UPDATED ANALYSIS OF KRAS/NRAS AND BRAF MUTATIONS IN STUDY 20050181 OF PANITUMUMAB plus FOLFIRI FOR 2ND-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (mCRC)
    Price, T. J.
    Peeters, M.
    Oliner, K. S.
    Cervantes, A.
    Sobrero, A. F.
    Ducreux, M.
    Hotko, Y.
    Andre, T.
    Chan, E.
    Lordick, F.
    Punt, C. J. A.
    Strickland, A. H.
    Wilson, G.
    Ciuleanu, T. E.
    Roman, L.
    Van Cutsem, E.
    Yu, H.
    Jung, A. S.
    Sidhu, R.
    Patterson, S. D.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 49 - 50
  • [30] Frequency of KRAS, NRAS, and BRAF mutations in colorectal cancer in an Argentinian population
    Barbier, Agustin
    Mendez, Guillermo
    Garino, Natalia
    Dibarbora, Delfina
    Salanova, Ruben
    Bertelli, Andrea Mendoza
    Ruiz, Alan
    Romero, Agustin
    Cantarella, Florencia
    Colombero, Cecilia
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)